BioMed Research International

Volume 2013 (2013), Article ID 546727, 10 pages

http://dx.doi.org/10.1155/2013/546727

Research Article

Development of an Ammonium Sulfate DNA Extraction Method for Obtaining Amplifiable DNA in a Small Number of Cells and Its Application to Clinical Specimens

Seo Young Oh,¹ Wook Youn Kim,² Tae Sook Hwang,² Hye Seung Han,² So Dug Lim,² and Wan Seop Kim²

¹Department of Animal Biotechnology, College of Animal Bioscience and Technology, Konkuk University, 1 Hwayang-dong, Gwangjin-gu, Seoul 143-701, Republic of Korea

²Department of Pathology, Konkuk University School of Medicine, 1 Hwayang-dong, Gwangjin-gu, Seoul 143-701, Republic of Korea

Received 4 January 2013; Revised 11 March 2013; Accepted 11 March 2013

Academic Editor: Gjumrakch Aliev

Copyright © 2013 Seo Young Oh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

DNA extraction from microdissected cells has become essential for handling clinical specimens with advances in molecular pathology. Conventional methods have limitations for extracting amplifiable DNA from specimens containing a small number of cells. We developed an ammonium sulfate DNA extraction method (A) and compared it with two other methods (B and C). DNA quality and quantity, β-globin amplification, and detectability of two cancer associated gene mutations were evaluated. Method A showed the best DNA yield, particularly when the cell number was very low. Amplification of the β-globin gene using DNA from the SNU 790 cell line and papillary thyroid carcinoma (PTC) cells extracted with Method A demonstrated the strongest band. BRAF V600E mutation analysis using ethanol-fixed PTC cells from a patient demonstrated both a “T” peak increase and an adjacent “A” peak decrease when 25 and 50 cells were extracted, whereas mutant peaks were too low to be analyzed using the other two methods. EGFR mutation analysis using formalin-fixed paraffin-embedded lung cancer tissues demonstrated a mutant peak with Method A, whereas the mutant peak was undetectable with Methods B or C. Method A yielded the best DNA quantity and quality with outstanding efficiency, particularly when paucicellular specimens were used.

1. Introduction

Molecular diagnosis combines molecular biology techniques with knowledge of molecular mechanisms of the disease and helps to diagnose causes of illness and to make a therapeutic decision. It usually uses diagnostic assays based on direct extraction of DNA or RNA from tissue sections or cytological preparations [1].

In clinical practice, a molecular diagnosis often requires isolation of genomic DNA from paucicellular clinical specimens such as fine needle aspirates, nipple fluid aspirates, sputum, bronchial wash fluid, buccal swabs, cervical smears, or urine [2–7]. If high-quality amplifiable DNA can be extracted from these specimens, various genetic tests including LOH analysis, gene copy number determination, genotyping, mutation analysis, or promoter methylation studies can be conducted for a molecular diagnosis [8–13]. As microdissected cells from clinical specimens have become important target material for molecular pathology, efficient genomic DNA extraction from a small number of microdissected cells has become a critical step for amplifying DNA [14]. Isolating DNA from a very small specimen using traditional methods is difficult and inefficient primarily due to DNA loss during filtration and precipitation. This often results in amplification failure when the quantity of starting material is limited. Several commercial DNA extraction kits have become available and have been promoted as alternatives to organic extraction methods to prepare DNA for amplification. They include adsorption of DNA on a silica membrane (Pinpoint Slide DNA Isolation System), an ion exchange resin (TaKaRa DEXPAT), and a salting-out procedure (Wizard Genomic DNA Purification Kit). As most extraction methods have a relatively low efficiency rate, van Oorschot et al. suggested to optimize methodologies specifically for trace samples so that one has the opportunity to (a) extract most of, if not all, the available DNA; (b) remove all amplification inhibiting elements without the loss of DNA; (c) utilize all of the extracted DNA for amplification; and (d) add the amplification reagents to the vessel containing the DNA rather than having to transfer the DNA to a separate vessel containing the amplification reagents (thus avoiding a further loss that could be encountered in the transfer step) [15].

The Pinpoint Slide DNA Isolation System was developed to easily isolate genomic DNA in any targeted microscopic tissue on a slide and is being used in laboratories handling trace samples particularly in forensic pathology [16, 17]. TaKaRa DEXPAT was designed to enable quick-step extraction of polymerase-chain-reaction- (PCR-) ready DNA from formalin-fixed paraffin-embedded (FFPE) tissue and small specimens and is currently used in many molecular diagnostic laboratories [18]. However, these kits have some limitations, as loss of DNA has been attributed to multiple steps (Pinpoint slide DNA isolation System) or protein contamination due to the absence of a digestion step (TaKaRa DEXPAT), particularly when samples are very small [16–18]. Therefore, obtaining amplifiable DNA using these commercial kits is often unsatisfactory due to the frequent handling of small specimens containing only a few clusters of target cancer cells. In fact, accurate evaluation data of these kits for isolating DNA from a small specimen has not been provided. Important factors to consider when evaluating extraction procedures include DNA yield and purity, suitability of the DNA for amplification, the number of transfer steps, time, and cost of the method [19].

To overcome these difficulties in clinical practice, we developed an ammonium sulfate DNA extraction method. In this study, we compared the quantity and quality of DNA extracted with this ammonium sulfate  DNA  extraction method with those of DNA extracted using two commercially available kits and a spectrophotometer readout for β-globin amplification, BRAF (v-raf murine sarcoma viral oncogene homolog B1)V600E, and epithelial growth factor receptor (EGFR) mutation analysis.

2. Materials and Methods

2.1. Specimen Preparation

2.1.1. Preparation of Human Papillary Thyroid Carcinoma (PTC) Cell Line

The SNU 790 human PTC cell line obtained from the Korean Cell Line Bank (Cancer Research Institute, Seoul National University, Seoul, Republic of Korea) was used. The cells were maintained in RPMI-1640 medium (Gibco, Grand Island, NY, USA) containing heat-inactivated 10% fetal bovine serum (Gibco). The cultures were maintained in humidified incubators at 37°C in an atmosphere of 5% CO₂ and 95% air. The cells were collected by centrifugation at 1,500 rpm for 5 minutes. The cell pellet was resuspended in 10 mL of fresh medium and counted using a hemocytometer. Tumor cells were diluted with fresh medium to cell concentrations of 50, 100, 200, 500, and 1000 cells/mL. After centrifugation at 1500 rpm for 10 minutes, the supernatant was discarded and 50 µL of each extraction buffer was added. The whole procedure was performed in triplicate after the tumor cells were harvested from the culture media.

2.1.2. Preparation of Nonparaffinized Cells on Archival Smear Slides

PTC cells from archival smear slides aspirated from the same patient in the Department of Pathology files of Konkuk University Medical Center were used. Study approval was obtained from the Institutional Review Board (KUH 1210027). The tumor cells were aspirated from the thyroid gland with a 26-gauge needle under ultrasound guidance and were smeared on glass slides and fixed with 95% ethanol. The fixed cells were stained using the Papanicolau procedure. After the target cells were marked by the cytopathologist, the cover slides were removed in xylene and air-dried. The slides were rinsed in 2% glycerol in TE buffer (10 Mm Tris-HCl pH 8.5, 1 mM EDTA, pH 8.0) for 2 minutes. The target cells were dissected with a 26-gauge needle under 100× magnification. Approximately, 25, 50, 100, 200, 500, and 1000 cells were dissected using a square micrometer in the microscope. A needle tip was carefully submerged in a tube containing 50 µL of each extraction buffer to collect the cells. For all cell number groups, the cells were collected three times for nucleic acid and mutation analyses and ten times to evaluate β-globin gene amplification.

2.1.3. Preparation of FFPE Tissue

No preparation step was required for Method A, whereas deparaffinization was required for Methods B and C. For tissue deparaffinization, 200 µL xylene was added to whole, half, and quarter portions of one tissue section (2 mm circle of 4 µm thickness) and agitated for 5 minutes, then centrifuged at 12,000 rpm for 10 minutes. The supernatant was removed and fresh xylene was added, and this step was repeated three times followed by washing with 100% ethanol for 10 minutes and centrifuging at 12,000 rpm for 10 minutes. Then, the tissue pellet was air-dried.

Fifty microliters of DNA extraction buffer solution from each protocol was added to the deparaffinized tissue in a 1.5 mL microcentrifuge tube followed by the DNA extraction step. DNA extraction without the deparaffinization step was also performed. The tissues were collected three times for EGFR mutation analysis.

2.2. DNA Extraction

2.2.1. Method A

Briefly, 50 μL of ammonium sulfate DNA extraction buffer solution (16 mM (NH₄)₂SO₄, 50 mM Tris-HCl pH 8.5, 1 mM EDTA pH 8.0, and 0.5% Tween-20) was added to the dissected cells or tissues in a 0.2 mL PCR tube, and Proteinase K (Takara Bio. Inc., Shiga, Japan) was added to a final concentration of 200 µg/mL and then digested at 56°C for 1 hour. Following the incubation, the PCR tube was heated to 100°C for 20 minutes in a PTC-220 Thermocycler (Bio-Rad, Hercules, CA, USA) with 10% Chelex-100 (Bio-Rad) after gentle shaking and centrifuged at 12,000 rpm for 10 minutes to elute the DNA.

2.2.2. Method B

Dissected cells and tissues were treated according to the manufacturer’s protocol for the Pinpoint Slide DNA Isolation System (Zymo Research, Irvine, CA, USA). Briefly, 50 μL of DNA extraction buffer was added to the 1.5 mL tube containing dissected cells or tissues and digested at 56°C for 4 hours after 5 μL of Proteinase K was added. After adding 100 μL of Pinpoint Binding Buffer, transfer to a Zymo-Spin1 Column and span the Column at 12000 rpm for 10 seconds. After washing 2 times by adding PP Wash Buffer to the Zymo-Spin1 Column and spining at 12000 rpm for 10 seconds, transfer the Column into a new 1.5 mL tube. Then, add the TE Buffer and span at 12000 rpm for 10 seconds to elute the DNA.

2.2.3. Method C

Dissected cells or tissues were heated to 100°C for 10 minutes with 50 μL of resin-based TaKaRa DEXPAT solution (Takara Bio. Inc., Shiga, Japan). The tube was centrifuged at 12,000 rpm for 10 minutes to elute the DNA.

2.3. Evaluation of Nucleic Acids

Each extract was brought to a final volume of 50 µL and the A₂₆₀ and A₂₈₀ were measured after diluting 2 µL of the extract in 498 µL of water using a DU-500 spectrophotometer (Beckman Coulter, Brea, CA, USA). DNA purity was determined by calculating the absorbance A₂₆₀/A₂₈₀ ratio. Pure DNA has a ratio of [20, 21]. The yield and purity of DNA from the SNU 790 cell line and PTC cells on the archival smear slides were measured from three specimens in each cell number group, and the mean value was calculated.

2.4. PCR Amplification of the β-Globin Gene

PCR amplification was performed using the SNU 790 cell line and PTC cells on archival smeared slides. The forward primer PC-3, 5′-ACACAACTGTGTTCACTAGC-3′ and reverse primer PC-4, 5′-CAACTTCATCCACGT TCACC-3′ were used to amplify a 110 bp DNA fragment. Briefly, 2 μL of DNA was added to a total 20 μL PCR solution mixture containing 0.2 mM of each dNTP, 1.5 mM MgCl₂, buffer, 1.5 U of Immolase DNA Taq. Polymerase (Bioline, London, UK), and 20 pmol of each primer. PCR was performed with an initial denaturation for 10 minutes at 95°C followed by five cycles (1 minute at 95°C, 1 minute at 55°C, 1 minute at 72°C), 35 cycles (1 minute at 95°C, 1 minute at 55°C, 1 minute at 72°C), and a 10-minute incubation at 72°C. The PCR products were analyzed by agarose gel electrophoresis to confirm successful amplification. β-Globin gene amplification PCR was performed from ten specimens in each cell number group.

2.5. Validation of β-Globin Gene Amplification

Approximately 25, 50, 100, 200, 500, and 1000 cells were scraped, and DNA was extracted from 95% alcohol-fixed (Merck KGaA, Darmstadt, Germany) PTC cells on archival smear slides using the three different methods. The amplified template was analyzed using the MultiNA Microchip Electrophoresis System DNA-500 kit (Shimadzu Corp., Tokyo, Japan). β-Globin gene amplification was performed as an internal control.

2.6. Mutation Analysis Using Pyrosequencing

The SNU 790 cell line and PTC cells on archival smear slides were used for analysis. The primer sequences for amplification of the mutation site on exon 15 were as follows: 5′-biotin-CTTCATAATGCTTGCTCTGATAGG-3′ (F) and 5′-GGCCAAAAATTTAATCAGTGGAA-3′ (R). Five microliters of DNA was added to a total 50 μL PCR solution mixture containing 0.2 mM of each dNTP, 1.5 mM MgCl₂, buffer, 1.5 U of Immolase DNA Taq polymerase, and 20 pmol of each primer. PCR was carried out with an initial denaturation for 5 minutes at 95°C followed by 40 cycles (30 seconds at 95°C, 30 seconds at 55°C, and 30 seconds at 72°C) and a 10-minute incubation at 72°C. The PCR products were analyzed by agarose gel electrophoresis to confirm successful amplification.

The biotinylated products were then immobilized to streptavidin-coated beads using the solution from a commercial PSQTM96 Sample Preparation kit. Three microliters of beads were diluted in binding buffer with 10 μL of biotinylated PCR products and incubated for 10 minutes at room temperature. The beads was then transferred to a filter probe, and liquid was removed by vacuum filtration. The DNA in the denaturation solution was separated, templates were washed with washing buffer, transferred to a PSQ 96 SNP plate, and annealed with a sequencing primer (5′-CCACTCCATCGAGATTT-3′) in buffer at room temperature. Finally, the specimens were analyzed using a PyroMark ID System with a SNP reagent kit for sequencing [22, 23]. The BRAF V600E mutation analysis was performed with three specimens from each cell number group.

2.7. EGFR Mutation Analysis Using Pyrosequencing

FFPE human lung cancer tissues were used for this analysis. The primer sequences for amplification of the EGFR mutation site on exon 19 and sequencing were 5′-GCATGTGGCACCATCTCA-3′(F), 5′-biotin-AAAAGGTGGGCCTGAGGTT-3′(R), and 5′-ATTCCCGTCGCTATC-3′, respectively. Whole procedure was performed as previously described for the BRAF mutation analysis except for the annealing condition (30 seconds at 60°C).

2.8. Statistical Analysis

We used analysis of variance to compare the means of DNA yields from the three different DNA extraction methods. Differences in β-globin amplification among the DNA extraction methods were analyzed by the two-tailed Fisher’s exact test and verified by Student’s t-test. A   value <0.05 was considered significant.

3. Results

3.1. Nucleic Acid Evaluation

Table 1 shows the mean total amount, concentration, and purity of DNA using the three different techniques in various numbers of cells from the SNU 790 cell line and PTC cells on archival smear slides.

Table 1: Comparison of DNA yield and purity extracted using three different methods from various numbers of SNU 790 cell line.

No. of cells
Extraction method
DNA concentration (ng/μL)
Total DNA yield

(ng)
Purity A₂₆₀/A₂₈₀
P value*

50

(n = 3)
A
0.124 ± 0.005
6.180 ± 0.38
1.7 ± 0.1
P = 0.001

B
0.067 ± 0.004
3.367 ± 0.39
1.2 ± 0.5

C
0.066 ± 0.006
3.320 ± 0.39
1.3 ± 0.1

100

(n = 3)
A
0.183 ± 0.007
9.153 ± 0.39
1.5 ± 0.1
P = 0.001

B
0.088 ± 0.023
4.380 ± 0.36
1.6 ± 0.1

C
0.085 ± 0.006
4.240 ± 0.29
1.6 ± 0.1

200

(n = 3)
A
0.260 ± 0.008
12.980 ± 0.41
1.6 ± 0.0
P = 0.003

B
0.157 ± 0.011
7.873 ± 0.55
1.8 ± 0.1

C
0.163 ± 0.031
8.165 ± 0.81
1.4 ± 0.0

500

(n = 3)
A
0.598 ± 0.067
29.900 ± 0.74
1.8 ± 0.1
P = 0.000

B
0.246 ± 0.006
12.293 ± 0.87
1.6 ± 0.0

C
0.296 ± 0.020
14.782 ± 0.73
1.7 ± 0.1

1000

(n = 3)
A
1.125 ± 0.089
57.653 ± 5.90
1.7 ± 0.2
P = 0.010

B
0.451 ± 0.031
22.527 ± 2.59
1.8 ± 0.0

C
0.761 ± 0.026
38.033 ± 2.62
1.6 ± 0.2

A: ammonium sulfate DNA extraction method; B: Pinpoint Slide DNA Isolation System; C: TaKaRa DEXPAT.

Analysis of variance.

Mean value ± standard deviation.

After analyzing the DNA from the SNU 790 cell line, the mean concentration (mean total amount) of DNA ranged from 0.124 to 1.125 ng/µL (6.180 to 57.653 ng) for Method A, 0.067 to 0.451 ng/µL (3.367 to 22.527 ng) for Method B, and 0.066 to 0.761 ng/µL (3.320 to 38.033 ng) for Method C. A₂₆₀ values ranged from 0.0025 to 0.0231 for Method A, 0.0013 to 0.0090 for Method B, and 0.0013 to 0.0152 for Method C. The purity (A₂₆₀/A₂₈₀) of DNA ranged from 1.5 to 1.8 for Method A, 1.6 to 1.8 for Method B, and 1.4 to 1.6 for Method C. Method A showed a better yield than that of the other two methods for all specimens (Table 1).

After analyzing the PTC cells on archival smear slides, the mean concentration (mean total amount) of DNA ranged from 0.013 to 0.406 ng/µL (0.652 to 20.280 ng) for Method A, 0.001 to 0.242 ng/µL (0.070 to 12.115 ng) for Method B, and 0.004 to 0.307 ng/µL (0.190 to 15.347 ng) for Method C. A₂₆₀ values ranged from 0.0003 to 0.0081 for Method A, 0.0000 to 0.0048 for Method B, and 0.0001 to 0.0061 for Method C. The purity (A₂₆₀/A₂₈₀) of DNA ranged from 1.5 to 1.8 for Method A, 1.2 to 1.8 for Method B, and 1.3 to 1.7 for Method C. Method A provided a DNA yield up to nine times greater when the cell number was very small (25–50 cells) (Table 2).

Table 2: Comparison of DNA yield and purity extracted using three different methods from various numbers of PTC cells on archival smear slide.

No. of cells
Extraction method
DNA concentration (ng/μL)
Total DNA yield (ng)
Purity A₂₆₀/A₂₈₀
P value*

25

()
A
0.013 ± 0.002
0.652 ± 0.081
1.6 ± 0.1
P = 0.001

B
0.001 ± 0.001
0.070 ± 0.041
1.0 ± 0.0

C
0.004 ± 0.002
0.190 ± 0.122
1.4 ± 0.2

50

()
A
0.059 ± 0.007
2.975 ± 0.337
1.7 ± 0.2
P = 0.000

B
0.007 ± 0.003
0.327 ± 0.175
1.2 ± 0.1

C
0.017 ± 0.006
0.834 ± 0.277
1.3 ± 0.2

100

()
A
0.104 ± 0.008
5.184 ± 0.388
1.5 ± 0.2
P = 0.001

B
0.056 ± 0.007
2.777 ± 0.356
1.6 ± 0.2

C
0.085 ± 0.006
4.241 ± 0.291
1.6 ± 0.3

200

()
A
0.179 ± 0.008
8.947 ± 0.413
1.6 ± 0.2
P = 0.000

B
0.075 ± 0.011
3.745 ± 0.550
1.8 ± 0.3

C
0.136 ± 0.016
6.797 ± 0.812
1.4 ± 0.2

500

()
A
0.291 ± 0.015
14.560 ± 0.741
1.8 ± 0.1
P = 0.000

B
0.139 ± 0.017
6.941 ± 0.871
1.6 ± 0.0

C
0.190 ± 0.015
9.486 ± 0.732
1.7 ± 0.1

1000

()
A
0.406 ± 0.009
20.280 ± 0.457
1.7 ± 0.0
P = 0.020

B
0.242 ± 0.052
12.115 ± 2.585
1.8 ± 0.1

C
0.307 ± 0.052
15.347 ± 2.623
1.6 ± 0.1

A: ammonium sulfate DNA extraction method; B: Pinpoint Slide DNA Isolation System; C: TaKaRa DEXPAT; PTC: papillary thyroid carcinoma.

Analysis of variance.

Mean value ± standard deviation.

3.2. β-Globin Gene Amplification Status Using DNA from Samples with Various Numbers of Cells

β-Globin gene amplification status was analyzed to compare the quality of the methods for extracting DNA from various numbers of SNU 790 cells and PTC cells on archival smear slides. Amplification of the β-globin gene using DNA from the SNU 790 cell line extracted with Method A demonstrated the strongest band, whereas Methods B and C produced weaker and irregular bands for all specimens. Method A demonstrated an amplified product when 25 and 50 PTC cells from the archival smear slide were used, whereas at least 100–200 cells were required for amplification using Methods B and C (Figure 1).

Figure 1: Comparison of β-globin gene amplification using DNA extracted from various numbers of SNU 790 cells and PTC cells on archival smear slides. We compared PCR products amplified from DNA extracted using three different methods to determine the efficacy of DNA extraction. This assay used β-globin primers that amplify a 110 bp fragment of genomic DNA. (a) Ammonium sulfate DNA extraction method; (b) Pinpoint Slide DNA Isolation System; (c) TaKaRa DEXPAT; PTC: papillary thyroid carcinoma.

To verify the efficiency of amplification extracted with the three methods, we compared the success rate of β-globin gene amplification using various numbers of target cells. Table 3 shows the successful β-globin gene amplification status using DNA from PTC cells on archival smear slides. Method A produced an amplifiable β-globin gene more frequently than that of the other methods when starting cell counts were <. The amplified β-globin gene was similar for all methods when starting cell number was ≥ When 25 and 50 cells were extracted using Method A, successful β-globin gene amplification was significantly higher than that with Methods B or C . To verify the superiority of Method A, we quantified the template amount using the MultiNA Microchip Electrophoresis System DNA-500 Kit (Figure 2). Method A produced higher β-globin template quantity than that of the other methods for all numbers of cells.

Table 3: Successful β-globin gene amplification frequency using DNA extracted from various numbers of PTC cells on archival smear slides using the three different methods.

No. of cells
A
B
C

No. of β-globin amplification
P value*
No. of β-globin amplification
P value*
No. of β-globin amplification
P value*

25

()
9
0.011
0
0.002
3
0.206

50

()
9
0.011
3
0.206
4
0.527

100

()
10
0.002
8
0.058
8
0.058

200

()
10
0.002
8
0.058
8
0.058

500

()
10
0.002
10
0.002
9
0.011

1000 ()
10
0.002
10
0.002
10
0.002

A: ammonium sulfate DNA extraction method; B: Pinpoint Slide DNA Isolation System; C: TaKaRa DEXPAT; PTC: papillary thyroid carcinoma. *Two-tailed Fisher's exact test.

(a)

(b)

(c)

Figure 2: Comparison of template quantity during β-globin gene amplification using various numbers of PTC cells on archival smear slides. (a) Ammonium sulfate DNA extraction method; (b) Pinpoint Slide DNA Isolation System; (c) TaKaRa DEXPAT; PTC: papillary thyroid carcinoma.

3.3. Determining the Efficiency of the Mutation Analysis in Nonparaffinized Cells

We analyzed the mutation in different numbers of target cells to confirm the efficiency of Method A in cytology specimens. Data using various numbers of PTC cells on archival smear slides are shown in Figure 3. The intensity of the “T” peak signal height ranged from 21 to 36% with Method A, 0 to 39% with Method B, and 0 to 34% with Method C. When 25 and 50 cells were extracted, Method A detected both the increase in the “T” peak (21 and 25%, resp.) and the decrease in the adjacent “A” peak (79 and 75%, resp.), whereas sequence peaks were too low to be analyzed by the other two methods. When 100 cells were used, Method A showed a significant increase in the “T” peak and a decrease in the “A” peak, and the “T” peak signal began to appear in Methods B and C. When 200 cells were used, Methods B and C showed the “T” peak signal, although the signal was lower than that of Method A. No significant difference was observed among the three methods when 500 cells were extracted.

(a)

(b)

(c)

Figure 3: Comparison of the efficiency of DNA extraction by examining the mutation detectability in various numbers of PTC cells on archival smear slides. (a) Ammonium sulfate DNA extraction method; (b) Pinpoint Slide DNA Isolation System; (c) TaKaRa DEXPAT; PTC: papillary thyroid carcinoma; *N/A: not applicable.

In contrast, all three methods were able to identify mutant peaks in the BRAF V600E analysis using the SNU 790 cell line, although the mutant peak was very low in Methods B and C when 50 cells were used. Taken together, Method A provided superior efficiency when sequencing a small number of cells.

3.4. Determining the Efficiency of the Mutation Analysis in FFPE Tissue

To confirm the efficiency of Method A in FFPE tissue specimens, we analyzed the EGFR mutation in different amounts of FFPE human lung cancer tissue using the PyroMark ID System (Figure 4). Amplification of the EGFR gene using DNA extracted by Method A demonstrated a mutant peak signal with detectable height and a stable baseline in all specimens with a strong band shown in whole and half tissue sections but a relatively weak band for the quarter tissue section. Method B, with a deparaffinization step, showed a weak band and an undetectable mutant peak for all specimens. Method C, with a deparaffinization step, showed the mutant peak signal only when the whole tissue section was used. No band was detected when Methods B and C were used to amplify the EGFR gene (data not shown).

Figure 4: Comparison of the efficiency of DNA extraction by examining the EGFR mutation in different amounts of FFPE tissue. (a) Ammonium sulfate DNA extraction method; (b) Pinpoint Slide DNA Isolation System; (c) TaKaRa DEXPAT; PTC: papillary thyroid carcinoma. 1: whole tissue; 2: 1/2 of one section; 3: 1/4 of one section (2 mm circle with a 4 µm thickness).

4. Discussion

Molecular diagnosis provides important information about the molecular characteristics of a disease, which is critical for diagnostic and therapeutic decision-making. In this respect, obtaining high-quality amplifiable DNA from cytological specimens or small biopsy specimens containing, only a few target cells is very important to prevent repeated invasive procedures in clinical practice.

In this study, we compared Method A with two different commercial DNA extraction methods using cell lines, microdissected cells smeared on glass slides, and FFPE tissues. DNA extraction from these microdissected cells was quite challenging.

DNA quantity and quality were estimated by DNA concentration and DNA purity. The quantity of nucleic acids in a solution is often estimated based on the absorbance of light at a wavelength of 260 nm. An A₂₆₀ value of 1.0 correlates roughly with double-stranded DNA content of 50 μg/mL. The A₂₈₀ value is traditionally taken as a measure of protein content in a solution (though nucleic acids absorb a considerable amount of light at 280 nm), and the A₂₆₀/A₂₈₀ ratio is a measure of nucleic acid extract purity. An A₂₆₀/A₂₈₀ ratio of is generally considered relatively free of protein contamination [24, 25]. Method A yielded the highest DNA concentration (Table 1) and the best amplified β-globin gene products when all cell number quantities were tested, particularly for the smallest cell (25 cells) number group (Table 3 and Figure 1). DNA purity obtained by Method A was in the 1.5 to 1.8 range and demonstrated little protein contamination. Method A was superior to the other two methods when applied to alcohol-fixed archival cytology specimens as determined by the peak on the MultiNA microchip obtained by electrophoresing β-globin template quantity (Figure 2).

The pyrosequencing assay was designed to begin sequence analysis immediately at the mutation site. A sequential nucleotide dispensation protocol was used that reflects the expected order of nucleotide incorporation and the potential base changes. Peak signal heights are proportional to the number of nucleotides that are incorporated with each dispensation [26]. When the mutation analysis was used to determine the efficiency of DNA extraction, no significant difference in the sequence change was observed among all three methods when the SNU 790 cell line was used. However, Figure 3 shows significant differences for detecting the mutation when PTC cells on archival smear slides were used. Notably, both the increase in “T” peak signal height and decrease in the adjacent “A” peak signal height were present when 25 and 50 cells were used in Method A. This was in contrast to the two other methods where sequence peaks were too low to be observed (Figure 3). These results suggest that our ammonium sulfate DNA extraction method provided superior quality and yield in paucicellular clinical specimens.

The increased yields of Method A may be attributed to the extraction buffer components, the appropriate concentration of Proteinase K (200 µg/mL), and optimum temperature. The alkaline (pH 8–11) of the extraction buffer containing ammonium sulfate aided protein precipitation due to hydrophobic interactions and ultimately provided good DNA quantity and quality. A precise amount of Proteinase K in the extraction buffer and optimum reaction temperature promote the inactivation of nucleases and DNA release from target cells [27–29]. High-temperature heating and an alkaline solution have been used to improve nucleic acid extraction from archival smeared cells and FFPE tissues and provide the best results as indicated by both the quantity and quality of DNA yield [30]. These conditions help to denature and hydrolyze proteins, resulting in rupture of cellular and nuclear membranes and breakage of cross-links introduced by fixation [30, 31].

Because clinical specimens often have a limited number of cells, a reproducible and cost-effective DNA extraction method is absolutely needed. Method A demonstrated the possibility of successful molecular genetic testing even with 25 target cells. This minimum requirement of 25 cells is overwhelmingly advantageous, as it provides the ability to apply various molecular techniques to cytological specimens. If cytological specimens such as bronchial wash specimens could replace lung biopsy specimens when analyzing EGFR mutation status in patients with inoperable lung cancer, it would be a powerful option, as repeated lung biopsy could be avoided in patients with poor clinical condition. In addition to the cytological specimens, histological specimens could also benefit by applying Method A. Even small biopsy specimens containing only a few clusters of target cells could be utilized for molecular analysis. In practice, small biopsy specimens are often not available for additional genetic testing. In that case, genetic tests can still be performed using previously stained slides.

In addition to these benefits, Method A also has practical advantages of being faster, easier, and simpler than Method B (required 1 hour of deparaffinization, a 4-hour digestion, and complicated DNA purification steps). The procedures of Method C are as simple and easy as Method A. However, this method does not have Proteinase K digestion step which is critical for protein lysis. This method also required a deparaffinization step, which is not necessary in Method A (Figure 4). These benefits can save significant time and effort when conducting DNA extractions in hospital-based molecular pathology laboratories.

In conclusion, Method A yielded the highest quantity and quality of DNA with outstanding efficiency particularly when paucicellular specimens were used. In addition, this extraction method provides an opportunity to apply molecular techniques to small FFPE tissue and archival cytology specimens.

Acknowledgment

This work was supported by the Konkuk University Medical Center Research Grant 2010.

References

M. Salto-Tellez and E. S. C. Koay, “Molecular diagnostic cytopathology: definitions, scope and clinical utility,” Cytopathology, vol. 15, no. 5, pp. 252–255, 2004.

A. M. Bofin, B. Ytterhus, C. Martin, J. J. O'Leary, and B. M. Hagmar, “Detection and quantitation of HER-2 gene amplification and protein expression in breast carcinoma,” American Journal of Clinical Pathology, vol. 122, no. 1, pp. 110–119, 2004.

C. Isaacs, L. R. Cavalli, Y. Cohen et al., “Detection of LOH and mitochondrial DNA alterations in ductal lavage and nipple aspirate fluids from high-risk patients,” Breast Cancer Research and Treatment, vol. 84, no. 2, pp. 99–105, 2004.

H. A. Phillips, G. C. W. Howard, and W. R. Miller, “Pilot studies on the p53 gene in nipple aspirate fluid from patients with breast cancer,” Breast Cancer Research and Treatment, vol. 61, no. 2, pp. 139–143, 2000.

M. Kersting, C. Friedl, A. Kraus, M. Behn, W. Pankow, and M. Schuermann, “Differential frequencies of p16(INK4a) promoter hypermethylation, p53 mutation, and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers,” Journal of Clinical Oncology, vol. 18, no. 18, pp. 3221–3229, 2000.

A. H. Walker, D. Najarian, D. L. White, J. M. Jaffe, P. A. Kanetsky, and T. R. Rebbeck, “Collection of genomic DNA by buccal swabs for polymerase chain reaction-based biomarker assays,” Environmental Health Perspectives, vol. 107, no. 7, pp. 517–520, 1999.

D. Seripa, P. Parrella, M. Gallucci et al., “Sensitive detection of transitional cell carcinoma of the bladder by microsatellite analysis of cells exfoliated in urine,” International Journal of Cancer, vol. 95, pp. 364–569, 2001.

D. M. Euhus, L. Cler, N. Shivapurkar et al., “Loss of Heterozygosity in benign breast epithelium in relation to breast cancer risk,” Journal of the National Cancer Institute, vol. 94, no. 11, pp. 858–860, 2002.

D. Bu, C. Lewis, L. Cler, and K. Elias, “Comparative real-time PCR for the detection of c-Myc, cyclin D1 and Her-2/neu gene amplification in breast fine needle aspirates,” American Association for Cancer Research, 2003

S. S. Wang, K. Thornton, A. M. Kuhn, J. G. Nadeau, and T. J. Hellyer, “Homogeneous real-time detection of single-nucleotide polymorphisms by strand displacement amplification on the BD ProbeTec ET system,” Clinical Chemistry, vol. 49, no. 10, pp. 1599–1607, 2003.

L. F. Zhang, W. M. Gao, R. Gealy et al., “Comparison of K-ras gene mutations in tumour and sputum DNA of patients with lung cancer,” Biomarkers, vol. 8, no. 2, pp. 156–161, 2003.

H. A. Phillips, G. C. W. Howard, and W. R. Miller, “p53 mutations as a marker of malignancy in bladder washing samples from patients with bladder cancer,” British Journal of Cancer, vol. 82, no. 1, pp. 136–141, 2000.

C. M. Lewis, L. R. Cler, D. W. Bu et al., “Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk,” Clinical Cancer Research, vol. 11, no. 1, pp. 166–172, 2005.

L. Cler, D. Bu, C. Lewis, and D. Euhus, “A comparison of five methods for extracting DNA from paucicellular clinical samples,” Molecular and Cellular Probes, vol. 20, no. 3-4, pp. 191–196, 2006.

R. A. H. van Oorschot, K. N. Ballantyne, and R. J. Mitchell, “Forensic trace DNA: a review,” Investigative Genetics, vol. 1, no. 1, article 14, 2010.

X. Wang, T. Sawaguchi, Y. Fukushima, and A. Sawaguchi, “Analysis of DNA formalin fixed and paraffin embedded tissues,” Research and Practice in Forensic Medicine, vol. 43, pp. 81–884, 2000.

J. V. Timothy, N. B. Kaye, R. John Mitchell, and Roland A. H. van Oorschot, “The pinpoint DNA isolation system as a novel DNA sampling method in forensic biology,” Forensic Science International, vol. 3, no. 1, pp. e91–e92, 2011.

P. J. Paterson, S. Seaton, J. McLaughlin, and C. C. Kibbler, “Development of molecular methods for the identification of Aspergillus and emerging moulds in paraffin wax embedded tissue sections,” Journal of Clinical Pathology, vol. 56, pp. 368–3370, 2003.

N. Vandenberg, R. A. H. van Oorschot, and R. J. Mitchell, “An evaluation of selected DNA extraction strategies for short tandem repeat typing,” Electrophoresis, vol. 18, no. 9, pp. 1624–1626, 1997.

O. P. Popa, D. Murariu, and L. O. Popa, “Comparison of four DNA extraction method from invasive freshwater bivalve species (mollusca: bivalvia) in Romanian fauna,” Travaux du Muséum National d'Histoire Naturelle “Grigore Antipa”, vol. L, pp. 527–5536, 2007.

P. Daneshwar, S. U. Shahnoo, and S. Khoyratty, “Genomic DNA extraction from Victoria amazonica,” Plant Molecular Biology Reporter, vol. 22, pp. 195a–195j, 2004.

T. S. Hwang, “Molecular biologic techniques in cytopathologic diagnosis,” Korean Journal of Pathology, vol. 43, no. 5, pp. 387–392, 2009.

S. K. Kim, D. L. Kim, H. S. Han et al., “Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules,” Diagnostic Molecular Pathology, vol. 17, no. 2, pp. 118–125, 2008.

L. Zhang, T. Kirchhoff, C. J. Yee, and K. Offit, “A rapid and reliable test for BRCA1 and BRCA2 founder mutation analysis in paraffin tissue using pyrosequencing,” Journal of Molecular Diagnostics, vol. 11, no. 3, pp. 176–181, 2009.

J. A. Glasel, “Validity of nucleic acid purities monitored by 260 nm/280 nm absorbance ratios,” BioTechniques, vol. 18, no. 1, pp. 62–63, 1995.

R. Aplenc, E. Orudjev, J. Swoyer, B. Manke, and T. Rebbeck, “Differential bone marrow aspirate DNA yields from commercial extraction kits,” Leukemia, vol. 16, no. 9, pp. 1865–1866, 2002.

F. S. Baechtel, “The extraction, purification and quantification of DNA,” in Proceedings of the International Symposium on the Forensic Aspects of DNA Analysis, pp. 25–28, United States Government Printing Office, Washington, DC, USA, 1989.

H. Cabral, M. T. Ruiz, C. M. A. Ruiz Carareto, and G. O. Bonilla-Rodriguez, “A plant proteinase, extracted from Bromelia fastuosa, as an alternative to proteinase K for DNA extraction,” Drosophila Information Service, vol. 83, pp. 178–185, 2000.

http://www.completegenomics.com/FAQs/Extracting-and-Storing-DNA/What-is-the-effect-of-high-temperature-during-DNA-extraction-147670885.html

S. R. Shi, R. J. Cote, L. Wu et al., “DNA extraction from archival formalin-fixed, paraffin-embedded tissue sections based on the antigen retrieval principle: heating under the influence of pH,” Journal of Histochemistry and Cytochemistry, vol. 50, no. 8, pp. 1005–1011, 2002.

S. K. Banerjee, W. F. Makdisi, A. P. Weston, S. M. Mitchell, and D. R. Campbell, “Microwave-based DNA extraction from paraffin-embedded tissue for PCR amplification,” BioTechniques, vol. 18, no. 5, pp. 768–773, 1995.